Will Nobel Prize Winner Hold Up To Medical Establishment?
This month gives those of us with chronic Lyme disease something to really celebrate.
If you have been following along with the developments at Viral Genetics, you will be interested to know that Dr.Luc Montagnier, co-winner of the 2008 Nobel Prize for Medicine and the co-discoverer of the HIV virus, has joined Viral Genetics as a research consultant. He is the co-founder of the World Foundation for AIDS Research and Prevention and co-directs the Program for International Viral Collaboration.
Dr. Montagnier, was quoted as saying, “While some preventive candidate vaccines failed to protect against HIV infection, and since there is no treatment able to cure the disease, it is important to come back to basic research and to explore new ways of research and treatment such as those explored by Viral Genetics. This is why I joined the Advisory Board of this Company.”
This is a certain break in the log-jam of political posturing about Lyme disease. Already Viral Genetics, the biotechnology company that discovers and develops immune-based therapies, came upon particular simularities in the testing of HIV that allowed them to look at Lyme disease in a whole new way. It has been generally agreed upon that there needs to be agreement based on exact science not theories.
The purpose of the Viral Genetics Advisors is to provide independent wisdom and insight to assist Viral Genetics in the accomplishment of its medical and scientific objectives by providing advice that is consistent with best-in-class scientific and medical practices and principles.
Based on new information from ongoing AIDS and Lyme disease studies being led by head of research Dr. M. Karen Newell, PhD, new components of the mechanism of TNP, the Company’s drug compound, have been identified according to the Wall Street Journal.
Viral Genetics continues to aggressively seek out the appropriate individuals in relevant fields to assist as the studies continue to move forward. These will include highly sought-after individuals in many diverse fields of research.
The existing group and new advisers to be added have come together in an effort to spearhead Viral Genetics’ promising new model of targeted peptide therapies for AIDS and other immune disease as swiftly as possible.
This may be the best Holiday present we could have
Similar Posts:
- Will Viral Genetics Help Find New Lyme Disease Treatments?
- Great News re: Possible Lyme Vaccine from Viral Genetics
- Viral Genetics in the News Again re Chronic Lyme Disease
- How Many People Have Chronic Lyme Disease?
- Don’t Give Up Hope.
- Make Your Voice Count at Change.org
- Discovery of New Retrovirus XMRV Brings Hope to Millions of Sufferers.
- Stem Cell Therapy for Lyme Disease?
- Lyme Disease Grant For Better Diagnosis
- The Horrors of Mycoplasma
Thanks for visiting again - Please comment on the posts you read - everyone is interested in what you have to say.
April 16th, 2009 at 9:09 pm
VIRAL GENETICS (VRAL) GET ANOTHER GRANT $116,000 MORE. THIS COMPANY MAY REALLY HAVE THE ANSWERS. WE ALL SHOULD RALLY AND TRY TO HELP THIS LITTLE COMPANY THAT MAY SOMEDAY BE A HOUSEHOLD NAME.
August 2nd, 2009 at 3:25 am
Your post Jenna’s Lyme Blog « Will Nobel Prize Winner Hold Up To Medical Establishment? was very interesting when I found it over google on Sunday by my search for medical product. I have your blog now in my bookmarks and I visit your blog again, soon. Take care.